Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
22 Jul 2021
Historique:
received: 04 06 2021
revised: 18 07 2021
accepted: 19 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 17 8 2021
Statut: epublish

Résumé

The combination of natural products with standard chemotherapeutic agents offers a promising strategy to enhance the efficacy or reduce the side effects of standard chemotherapy. Doxorubicin (DOX), a standard drug for breast cancer, has several disadvantages, including severe side effects and the development of drug resistance. Recently, we reported the potential bioactive markers of Australian propolis extract (AP-1) and their broad spectrum of pharmacological activities. In the present study, we explored the synergistic interactions between AP-1 and DOX in the MCF7 breast adenocarcinoma cells using different synergy quantitation models. Biochemometric and metabolomics-driven analysis was performed to identify the potential anticancer metabolites in AP-1. The molecular mechanisms of synergy were studied by analysing the apoptotic profile via flow cytometry, apoptotic proteome array and measuring the oxidative status of the MCF7 cells treated with the most synergistic combination. Furthermore, label-free quantification proteomics analysis was performed to decipher the underlying synergistic mechanisms. Five prenylated stilbenes were identified as the key metabolites in the most active AP-1 fraction. Strong synergy was observed when AP-1 was combined with DOX in the ratio of 100:0.29 (

Identifiants

pubmed: 34360606
pii: ijms22157840
doi: 10.3390/ijms22157840
pmc: PMC8346082
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Antibiotics, Antineoplastic 0
Proteome 0
Doxorubicin 80168379AG
Propolis 9009-62-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Western Sydney University
ID : N/A
Organisme : Maxwell Family Foundation
ID : N/A
Organisme : NICM Health Research Institute
ID : N/A

Références

Methods Mol Biol. 2021;2223:169-182
pubmed: 33226595
Cancer Metastasis Rev. 2007 Jun;26(2):225-39
pubmed: 17440684
Cell Death Differ. 2004 Feb;11(2):208-16
pubmed: 14605674
Cancer Gene Ther. 2004 May;11(5):309-16
pubmed: 15031723
Nat Genet. 1999 Feb;21(2):236-40
pubmed: 9988281
J Biol Inorg Chem. 2011 Dec;16(8):1155-68
pubmed: 21706253
Eur J Cell Biol. 2013 Aug-Sep;92(8-9):247-56
pubmed: 24064045
Science. 1998 Aug 28;281(5381):1322-6
pubmed: 9735050
Biochem Pharmacol. 2011 Nov 15;82(10):1384-90
pubmed: 21689642
Drug Resist Updat. 2020 Mar;49:100671
pubmed: 31841768
JAMA. 2020 Apr 7;323(13):1266-1276
pubmed: 32259228
Int J Pharm. 2021 Jan 25;593:120117
pubmed: 33259901
Chemother Res Pract. 2012;2012:743193
pubmed: 23320171
Int J Oncol. 2016 Apr;48(4):1426-36
pubmed: 26848023
Methods Mol Biol. 2021;2279:213-223
pubmed: 33683697
Medicines (Basel). 2018 Dec 23;6(1):
pubmed: 30583596
Histol Histopathol. 1996 Jan;11(1):153-60
pubmed: 8720459
Biochem Pharmacol. 1999 Apr 1;57(7):727-41
pubmed: 10075079
Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95
pubmed: 10959836
Eur J Pharmacol. 2018 Jan 5;818:241-253
pubmed: 29074412
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6939-42
pubmed: 9192670
Drug Chem Toxicol. 2018 Jul;41(3):338-351
pubmed: 29319361
Arch Toxicol. 2016 Nov;90(11):2763-2777
pubmed: 26537877
J Biol Chem. 2007 Jan 19;282(3):1595-606
pubmed: 17079232
Lab Anim Res. 2017 Jun;33(2):165-170
pubmed: 28747983
Nat Cell Biol. 2005 Sep;7(9):909-15
pubmed: 16113678
Nutr Cancer. 2020;72(1):133-145
pubmed: 31112051
Anticancer Res. 2003 Jul-Aug;23(4):3311-6
pubmed: 12926068
Breast Cancer Res. 2007;9(6):R86
pubmed: 18078515
Food Chem Toxicol. 2019 Jan;123:72-97
pubmed: 30352300
J Oncol Pharm Pract. 2020 Mar;26(2):434-444
pubmed: 31594518
Cancer. 2000 Jul 1;89(1):123-34
pubmed: 10897009
Drug Discov Today. 2007 Jan;12(1-2):34-42
pubmed: 17198971
Oncol Rep. 2021 Apr;45(4):
pubmed: 33649820
Cell. 1996 Jul 12;86(1):147-57
pubmed: 8689682
Biomolecules. 2021 Jan 19;11(1):
pubmed: 33477996
Antioxidants (Basel). 2021 Feb 26;10(3):
pubmed: 33652780
Cells. 2021 Mar 30;10(4):
pubmed: 33808242
J Immunol Methods. 1994 Apr 15;170(2):211-24
pubmed: 8157999
J Biol Chem. 2003 Aug 8;278(32):30057-62
pubmed: 12766152
Biomed Pharmacother. 2018 Mar;99:411-421
pubmed: 29367110
Cell. 2017 Dec 14;171(7):1678-1691.e13
pubmed: 29245013
Biol Chem. 2017 Sep 26;398(10):1095-1108
pubmed: 28384098
J Biol Chem. 2008 Feb 22;283(8):5188-94
pubmed: 18086682
Nat Genet. 2000 May;25(1):115-9
pubmed: 10802669
Cancer. 2003 Mar 15;97(6):1573-81
pubmed: 12627523
Nan Fang Yi Ke Da Xue Xue Bao. 2015 Jun;35(6):883-7
pubmed: 26111690
Mol Cancer Ther. 2011 Jun;10(6):1046-58
pubmed: 21518729
Curr Med Chem. 2005;12(4):481-99
pubmed: 15720256
Biosci Biotechnol Biochem. 2004 Jan;68(1):260-2
pubmed: 14745198
BMC Cancer. 2011 May 23;11:191
pubmed: 21605372
Cells. 2019 Dec 19;9(1):
pubmed: 31861751
Cancer Lett. 1996 Jun 5;103(2):183-9
pubmed: 8635156
Evid Based Complement Alternat Med. 2014;2014:280120
pubmed: 24963320
Mol Cell. 2013 Mar 7;49(5):872-83
pubmed: 23333306
Nanotechnology. 2018 Aug 17;29(33):332002
pubmed: 29798934
IUBMB Life. 2019 Dec;71(12):1834-1845
pubmed: 31441584
N Engl J Med. 2003 Jun 5;348(23):2339-47
pubmed: 12788999
Cell. 2007 Jan 26;128(2):281-94
pubmed: 17254967
Br J Pharmacol. 2014 Dec;171(23):5345-60
pubmed: 25039894
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1956-65
pubmed: 18775851
Biomed Pharmacother. 2018 Sep;105:449-460
pubmed: 29879629
Neurochem Res. 2021 Apr;46(4):819-842
pubmed: 33439429
J Agric Food Chem. 2012 Nov 28;60(47):11765-70
pubmed: 23067056
Science. 2002 Nov 15;298(5597):1435-8
pubmed: 12364621
Biochem Pharmacol. 2004 Jan 1;67(1):53-66
pubmed: 14667928
Cancer Metastasis Rev. 2006 Dec;25(4):695-705
pubmed: 17160708
Life Sci. 2020 Jun 1;250:117599
pubmed: 32234491
Lancet. 2005 May 14-20;365(9472):1687-717
pubmed: 15894097
Chin Med. 2021 Apr 29;16(1):36
pubmed: 33926485
Br J Cancer. 1995 Oct;72(4):805-12
pubmed: 7547224
Cancer Biol Ther. 2009 Mar 15;8(6):555-63
pubmed: 19242108
Metabolites. 2019 Apr 13;9(4):
pubmed: 31013937
BMC Complement Altern Med. 2012 Oct 06;12:173
pubmed: 23038995
Cancer Treat Rev. 2018 Feb;63:79-95
pubmed: 29253837
Mol Cancer Ther. 2016 Jun;15(6):1155-62
pubmed: 26983881
J Biol Chem. 2014 Jan 10;289(2):827-37
pubmed: 24285542
Nat Struct Mol Biol. 2008 Jan;15(1):85-93
pubmed: 18066079
Cancer Res. 2001 Jan 1;61(1):348-54
pubmed: 11196185
Clin Biochem. 2002 Sep;35(6):489-93
pubmed: 12413611
Cancers (Basel). 2021 Feb 04;13(4):
pubmed: 33557316
Cell Death Differ. 2008 Mar;15(3):453-60
pubmed: 18174901
Neoplasma. 2015;62(4):666-73
pubmed: 25997966
J Environ Pathol Toxicol Oncol. 2014;33(3):219-31
pubmed: 25272060
Food Chem Toxicol. 2017 Feb;100:115-137
pubmed: 27915048
Anticancer Drugs. 2018 Jan;29(1):1-9
pubmed: 29099416
Cell. 1994 Jul 15;78(1):59-66
pubmed: 8033212
Nat Rev Microbiol. 2009 Jun;7(6):460-6
pubmed: 19444248
J Agric Food Chem. 2000 Sep;48(9):3876-84
pubmed: 10995285
Nano Lett. 2021 Feb 10;21(3):1484-1492
pubmed: 33475372
Folia Histochem Cytobiol. 2004;42(4):221-7
pubmed: 15704648
Histol Histopathol. 1996 Oct;11(4):851-60
pubmed: 8930626
Mol Biosyst. 2016 Mar;12(3):693-6
pubmed: 26726961
Oxid Med Cell Longev. 2018 May 2;2018:7074209
pubmed: 29854089
Cell. 2005 Dec 29;123(7):1213-26
pubmed: 16377563
Cell. 1995 May 19;81(4):505-12
pubmed: 7538907
Iran J Pharm Res. 2017 Winter;16(Suppl):2-23
pubmed: 29844772
J Basic Clin Pharm. 2016 Mar;7(2):27-31
pubmed: 27057123
Mutagenesis. 2007 Jul;22(4):247-53
pubmed: 17412712
Pharmacol Rev. 1989 Jun;41(2):93-141
pubmed: 2692037
Drug Chem Toxicol. 2020 May;43(3):240-254
pubmed: 30033764
Anticancer Res. 2007 Sep-Oct;27(5A):3075-82
pubmed: 17970047
Comput Struct Biotechnol J. 2015 Sep 25;13:504-13
pubmed: 26949479
Cancer Lett. 2006 Jan 18;231(2):215-27
pubmed: 16399223
J Clin Oncol. 2017 Aug 10;35(23):2647-2655
pubmed: 28398846
Adv Cancer Res. 2009;105:77-92
pubmed: 19879424
Breast Cancer Res Treat. 2009 Sep;117(1):219-21
pubmed: 18853248
J Diet Suppl. 2016;13(3):245-68
pubmed: 25723108
Science. 2005 Apr 22;308(5721):551-4
pubmed: 15790808
Nat Protoc. 2019 Feb;14(2):482-517
pubmed: 30664679
J Cell Physiol. 2004 Aug;200(2):223-34
pubmed: 15174092
Nature. 2003 Feb 27;421(6926):961-6
pubmed: 12607005
Nat Genet. 1994 Dec;8(4):392-8
pubmed: 7894492
Cancer Cell Int. 2018 Feb 20;18:24
pubmed: 29467594
Nat Commun. 2019 Feb 22;10(1):910
pubmed: 30796221
Molecules. 2019 Jul 10;24(14):
pubmed: 31295906
Phytochemistry. 2012 May;77:251-9
pubmed: 22321386
Bioinformatics. 2011 Oct 15;27(20):2917-8
pubmed: 21893519
Food Chem Toxicol. 1998 Apr;36(4):347-63
pubmed: 9651052
Cardiology. 2010;115(2):155-62
pubmed: 20016174
Cell Cycle. 2008 Nov 15;7(22):3584-94
pubmed: 19001859
Breast Cancer Res Treat. 2000 May;61(1):87-96
pubmed: 10930093
Iran J Basic Med Sci. 2017 May;20(5):538-551
pubmed: 28656089
J Med Microbiol. 2008 Jan;57(Pt 1):100-105
pubmed: 18065674
Cell Death Differ. 2009 Oct;16(10):1303-14
pubmed: 19662025
Nat Rev Drug Discov. 2005 Jan;4(1):71-8
pubmed: 15688074
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Nat Genet. 1996 Mar;12(3):298-302
pubmed: 8589721
J Oncol. 2020 Aug 25;2020:3634825
pubmed: 32908506
Pharmacol Rev. 2004 Jun;56(2):185-229
pubmed: 15169927
J Control Release. 2020 Dec 10;328:171-191
pubmed: 32866591
Phytother Res. 2021 Mar;35(3):1163-1175
pubmed: 32985744
Oncogene. 1995 Jun 15;10(12):2297-305
pubmed: 7540278
Cell Stress Chaperones. 2001 Oct;6(4):316-25
pubmed: 11795468
J Cancer Prev. 2020 Jun 30;25(2):70-78
pubmed: 32647648
Autophagy. 2008 Jul;4(5):669-79
pubmed: 18424910
Cancer Res. 2001 Dec 1;61(23):8578-85
pubmed: 11731445
Trends Pharmacol Sci. 2020 Apr;41(4):266-280
pubmed: 32113653
Sci Rep. 2015 Jul 07;5:11853
pubmed: 26149967
Acta Pharmacol Sin. 2007 Jul;28(7):1057-66
pubmed: 17588343
Eur J Pharmacol. 2019 Jan 15;843:162-176
pubmed: 30452912
Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494
pubmed: 29762782
BMC Cancer. 2008 May 02;8:129
pubmed: 18454859
Cancer Lett. 2018 Feb 28;415:177-186
pubmed: 29175460
Cancer Res. 1982 May;42(5):1955-61
pubmed: 7066906
Cell. 2000 Dec 22;103(7):1121-31
pubmed: 11163187
Food Funct. 2021 Mar 21;12(6):2498-2519
pubmed: 33683257
PLoS One. 2016 Aug 02;11(8):e0160312
pubmed: 27483141
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
Cancer. 2003 Jun 1;97(11):2869-79
pubmed: 12767102
Phytochemistry. 2017 Feb;134:87-97
pubmed: 27890584
Br J Haematol. 2002 Jul;118(1):229-38
pubmed: 12100152
Cancer Lett. 1996 Jun 5;103(2):233-9
pubmed: 8635162
Cancer Lett. 2000 Feb 28;149(1-2):21-9
pubmed: 10737704
Eur J Cancer Prev. 2019 Jul;28(4):365-372
pubmed: 29847456
Int J Mol Sci. 2012 Dec 24;14(1):411-20
pubmed: 23263670
Lung Cancer. 2008 May;60(2):277-84
pubmed: 18061304
Zhongguo Zhong Yao Za Zhi. 2006 Jan;31(2):141-4
pubmed: 16570804
Nat Rev Cancer. 2009 Feb;9(2):95-107
pubmed: 19165225
Neoplasia. 2004 Sep-Oct;6(5):440-8
pubmed: 15548352
Clin Cancer Res. 2011 Aug 1;17(15):5005-15
pubmed: 21653692
Biochemistry. 1991 Oct 1;30(39):9469-78
pubmed: 1892847
Phytother Res. 2010 Aug;24(8):1181-7
pubmed: 20077439
Arzneimittelforschung. 1953 Jun;3(6):285-90
pubmed: 13081480
Oncotarget. 2017 Jul 11;8(28):46663-46680
pubmed: 28445146
Anticancer Drugs. 2008 Sep;19(8):766-76
pubmed: 18690087
Nutrition. 2016 Nov-Dec;32(11-12):1171-8
pubmed: 27238957
Cell. 2017 Dec 14;171(7):1476-1478
pubmed: 29245008
Prostate. 1997 Sep 1;32(4):229-33
pubmed: 9288180
Oncogene. 1997 Dec 4;15(23):2817-26
pubmed: 9419972
J Biol Chem. 2004 Jun 11;279(24):25535-43
pubmed: 15054096
Reprod Biol. 2019 Mar;19(1):22-37
pubmed: 30827825
Br J Cancer. 2006 Feb 27;94(4):532-9
pubmed: 16450001
Mol Cell. 2005 Oct 7;20(1):65-75
pubmed: 16209946
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
Nucleic Acids Res. 2016 Jul 8;44(W1):W83-9
pubmed: 27098042
Molecules. 2021 Apr 12;26(8):
pubmed: 33921198
Cell Death Dis. 2018 Mar 12;9(3):392
pubmed: 29531225
Braz J Med Biol Res. 2009 Sep;42(9):854-62
pubmed: 19738990
Carcinogenesis. 1999 Jun;20(6):985-9
pubmed: 10357777
Gynecol Oncol. 2015 Jul;138(1):18-23
pubmed: 25925990
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
Nat Struct Biol. 2002 Jun;9(6):436-41
pubmed: 11967569
Science. 2013 Feb 8;339(6120):700-4
pubmed: 23306437
Nat Prod Res. 2011 Mar;25(6):606-13
pubmed: 21409722
Eur J Cancer. 2019 Jan;106:181-192
pubmed: 30528802
Pancreas. 2003 Jan;26(1):23-7
pubmed: 12499913
Nat Prod Commun. 2010 Jan;5(1):43-5
pubmed: 20184018
Biochem Pharmacol. 2014 May 15;89(2):217-23
pubmed: 24630930
Phytochem Anal. 2016 Mar-Apr;27(2):107-15
pubmed: 26662866
Drug Resist Updat. 2016 Nov;29:90-106
pubmed: 27912846
Mol Cancer. 2015 Feb 15;14:43
pubmed: 25743390
Biochem Pharmacol. 2014 Jan 15;87(2):254-83
pubmed: 24184505
J Pharm Belg. 1993 May-Jun;48(3):165-70
pubmed: 8410623
Ann Intern Med. 1979 Nov;91(5):710-7
pubmed: 496103
Int J Biochem Cell Biol. 2011 Dec;43(12):1708-19
pubmed: 21854868
PLoS Comput Biol. 2019 May 20;15(5):e1006752
pubmed: 31107860
Int J Nanomedicine. 2020 Dec 17;15:10285-10304
pubmed: 33376322
Cancer Res. 1998 Jan 15;58(2):256-62
pubmed: 9443402
Lancet Oncol. 2017 Oct;18(10):1397-1410
pubmed: 28882536
Drug Discov Today. 2019 Dec;24(12):2286-2298
pubmed: 31518641
Front Oncol. 2019 Jun 07;9:480
pubmed: 31231612
Nucleic Acids Res. 2019 Jul 2;47(W1):W43-W51
pubmed: 31066443
Cell Signal. 2015 Dec;27(12):2496-505
pubmed: 26404623
J Breast Cancer. 2016 Sep;19(3):231-241
pubmed: 27721872
Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a001222
pubmed: 20463003
Breast Cancer Res. 2003;5(1):45-52
pubmed: 12559046
Mol Cell. 2000 Oct;6(4):839-49
pubmed: 11090622
J Clin Oncol. 2000 Dec 15;18(24):4045-52
pubmed: 11118465
Antioxidants (Basel). 2021 Apr 22;10(5):
pubmed: 33922139
BMC Cancer. 2015 Feb 13;15:53
pubmed: 25884418
Free Radic Biol Med. 2017 Mar;104:144-164
pubmed: 28088622
Nat Rev Cancer. 2008 Apr;8(4):253-67
pubmed: 18354415

Auteurs

Muhammad A Alsherbiny (MA)

NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.
Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.

Deep J Bhuyan (DJ)

NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.

Ibrahim Radwan (I)

Faculty of Science and Technology, University of Canberra, Canberra, ACT 2617, Australia.

Dennis Chang (D)

NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.

Chun-Guang Li (CG)

NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH